crta
Hrvatska znanstvena Sekcija img
bibliografija
3 gif
 Naslovna
 O projektu
 FAQ
 Kontakt
4 gif
Pregledavanje radova
Jednostavno pretraživanje
Napredno pretraživanje
Skupni podaci
Upis novih radova
Upute
Ispravci prijavljenih radova
Ostale bibliografije
Slični projekti
 Bibliografske baze podataka

Pregled bibliografske jedinice broj: 951588

Časopis

Autori: Ajduković Jasna; Salamunić Ilza; Hozo Izet; Despalatović Bruna; Šimunić Miroslav; Bonacin Damir; Puljiz Željko; Trgo Gorana; Šundov Željko; Tonkić Ante.
Naslov: Soluble P-selectin glycoprotein ligand - a possible new target in ulcerative colitis.
( Soluble P-selectin glycoprotein ligand - a possible new target in ulcerative colitis. )
Izvornik: Bratislava medical journal (0006-9248) 116 (2015), 3; 147-149
Vrsta rada: članak
Ključne riječi: ulcerative colitis, P-selectin glycoprotein ligand-1.
( ulcerative colitis, P-selectin glycoprotein ligand-1. )
Sažetak:
Background: The main characteristic of active infl ammatory bowel disease (IBD) is the neutrophil infi ltration into the intestinal lamina propria, where neutrophils usually do not reside. Selectins are cell surface glycoproteins responsible for binding the leukocytes to vascular cells and their extravasation into the surrounding tissue. They show high affi nity to P-selectin glycoprotein ligand-1 (PSGL-1) receptors. PSGL-1 is expressed on the surface of all leukocytes and they mediate the rolling of neutrophils on P-selectin. Soluble PSGL-1 acts competitively with cellular PSGL in many physiological and pathological processes. The aim of our study was to compare serum sPSGL-1 concentration in the blood of patients with ulcerative colitis (UC) and healthy control subjects. Methods: Serum concentrations of sPSGL-1 were measured in 20 patients with UC and 20 control subjects. Two-layer immunoenzyme procedure (ELISA) was used. Results: The mean (± standard deviation) serum concentrations of sPSGL-1 in patients with UC and controls were 349.97±75.40 U/mL and 284.39±52.40 U/mL, respectively (p=0.003). Conclusion: In the present study, we showed that patients with UC had signifi cantly higher sPSGL-1 blood values in comparison with healthy subjects. A short-term blockade with anti-PSGL-1 antibodies could block the transport of neutrophils and decrease UC activity. Thus it could possibly be employed in a new therapeutic approach to the treatment of UC (Fig. 1, Ref. 25). Text in PDF www.elis.sk. Key words: ulcerative colitis, P-selectin glycoprotein ligand-1.
Izvorni jezik: eng
Kategorija: Znanstveni
Broj citata:
Altmetric:
DOI: 10.4149/BLL_2015_029
URL cjelovitog teksta:
Časopis izlazi u samo elektroničkom izdanju: NE
Google Scholar: Soluble P-selectin glycoprotein ligand - a possible new target in ulcerative colitis.
Upisao u CROSBI: Jasna Ajduković (jasna.ajdukovic@gmail.com), 28. Kol. 2018. u 19:02 sati
Napomene:
rad je indeksiran u CC



Verzija za printanje   za tiskati


upomoc
foot_4